Skip to main content
Erschienen in: Annals of Surgical Oncology 1/2016

01.01.2016 | Breast Oncology

Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment

verfasst von: Isabel T. Rubio, MD, PhD, Antonio Esgueva-Colmenarejo, MD, Martin Espinosa-Bravo, MD, PhD, Juan Pablo Salazar, MD, Ignacio Miranda, MD, Vicente Peg, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Intraoperative ultrasound (IOUS)-guided lumpectomy in early breast cancer has shown advantages over other techniques. However, the use of IOUS has been less explored after neoadjuvant treatment (NAT). This study aimed to compare IOUS- and wire localization (WL)-guided surgery in breast cancer patients after NAT.

Methods

The study enrolled patients treated with NAT who underwent breast-conserving surgery (BCS) between July 2008 and December 2012. For the patients with a hydrogel marker or residual tumor visible on ultrasound, an IOUS-guided surgery was performed (IOUS group). The patients with a standard marker or hydrogel marker not visible on ultrasound underwent a WL-guided surgery (WL group).

Results

The study investigated 214 patients: 145 (67.8 %) in the IOUS group and 69 (32.2 %) in the WL group. The patient and tumor characteristics were comparable between the two groups. For the patients who had a pathologic complete response (pCR) or microscopic disease, the volume excised was lower in the IOUS group (p = 0.03). The rate of reexcision for positive or close margins was similar in the two groups (p = 0.80). After a median follow-up period of 43 months, the local recurrence rates did not differ significantly between the two groups.

Conclusions

Compared with WL surgery, IOUS seems to lower the volume of resection in patients with pCR or minimal microscopic disease after NAT without compromising margins and local recurrences. BCS can easily be achieved with IOUS for patients with a good response after NAT.
Literatur
1.
Zurück zum Zitat Kaufmann M, von Minckwitz G, Bear H, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol. 2007;18:1927–34.PubMedCrossRef Kaufmann M, von Minckwitz G, Bear H, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol. 2007;18:1927–34.PubMedCrossRef
2.
Zurück zum Zitat Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672–85.PubMed Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672–85.PubMed
3.
Zurück zum Zitat Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. J Clin Oncol. 2008;26:778–85.PubMedCrossRef Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. J Clin Oncol. 2008;26:778–85.PubMedCrossRef
4.
Zurück zum Zitat van der Hage JA, van de Velde CJ, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902. J Clin Oncol. 2001;19:4224–37.PubMed van der Hage JA, van de Velde CJ, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902. J Clin Oncol. 2001;19:4224–37.PubMed
5.
Zurück zum Zitat Chen A, Meric-Bernstam F, Hunt K, et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol. 2004;22:2303–12.PubMedCrossRef Chen A, Meric-Bernstam F, Hunt K, et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol. 2004;22:2303–12.PubMedCrossRef
6.
Zurück zum Zitat Kuerer HM, Hunt KK, Newman LA, Ross MI, Ames FC, Singletary SE. Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. J Am Coll Surg. 2000;190:350–63.PubMedCrossRef Kuerer HM, Hunt KK, Newman LA, Ross MI, Ames FC, Singletary SE. Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. J Am Coll Surg. 2000;190:350–63.PubMedCrossRef
7.
Zurück zum Zitat Bear HD. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B27. J Clin Oncol. 2003;21:4165–74.PubMedCrossRef Bear HD. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B27. J Clin Oncol. 2003;21:4165–74.PubMedCrossRef
8.
Zurück zum Zitat Minckwitz von G, Untch M, Blohmer J-U, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30:1796–804.CrossRef Minckwitz von G, Untch M, Blohmer J-U, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30:1796–804.CrossRef
9.
Zurück zum Zitat Baselga J, Bradbury I, Eidtmann H, NeoALTTO Study Team, et al. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomized, open-label, multicentre, phase 3 trial. Lancet. 2012;379:633–40.PubMedCrossRef Baselga J, Bradbury I, Eidtmann H, NeoALTTO Study Team, et al. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomized, open-label, multicentre, phase 3 trial. Lancet. 2012;379:633–40.PubMedCrossRef
10.
Zurück zum Zitat Donker M, Drukker CA, Valdes Olmos RA, et al. Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL technique. Ann Surg Oncol. 2013;20:2569–72.PubMedCrossRef Donker M, Drukker CA, Valdes Olmos RA, et al. Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL technique. Ann Surg Oncol. 2013;20:2569–72.PubMedCrossRef
11.
Zurück zum Zitat Espinosa-Bravo M, Sao Avilés A, Esgueva A, et al. Breast-conservative surgery after neoadjuvant chemotherapy in breast cancer patients: comparison of two tumor localization methods. Eur J Surg Oncol. 2011;37:1038–43.PubMedCrossRef Espinosa-Bravo M, Sao Avilés A, Esgueva A, et al. Breast-conservative surgery after neoadjuvant chemotherapy in breast cancer patients: comparison of two tumor localization methods. Eur J Surg Oncol. 2011;37:1038–43.PubMedCrossRef
12.
Zurück zum Zitat Ramos M, Diez JC, Ramos T, Ruano R, Sancho M, Gonzalez-Orus JM. Intraoperative ultrasound in conservative surgery for non palpable breast cancer after neoadjuvant chemotherapy. Int J Surg. 2014;12:572–7.PubMedCrossRef Ramos M, Diez JC, Ramos T, Ruano R, Sancho M, Gonzalez-Orus JM. Intraoperative ultrasound in conservative surgery for non palpable breast cancer after neoadjuvant chemotherapy. Int J Surg. 2014;12:572–7.PubMedCrossRef
13.
Zurück zum Zitat Rubio IT, Henry-Tillman R, Klimberg VS. Surgical use of breast ultrasound. Surg Clin North Am. 2003;83:771–88.PubMedCrossRef Rubio IT, Henry-Tillman R, Klimberg VS. Surgical use of breast ultrasound. Surg Clin North Am. 2003;83:771–88.PubMedCrossRef
14.
Zurück zum Zitat Krekel NMA, Zonderhuis BM, Stockmann HBAC, et al. A comparison of three methods for nonpalpable breast cancer excision. Eur J Surg Oncol. 2011;37:109–15.PubMedCrossRef Krekel NMA, Zonderhuis BM, Stockmann HBAC, et al. A comparison of three methods for nonpalpable breast cancer excision. Eur J Surg Oncol. 2011;37:109–15.PubMedCrossRef
15.
Zurück zum Zitat Cox CE, Furman B, Stowell N, et al. Radioactive seed localization breast biopsy and lumpectomy: can specimen radiograph be eliminated? Ann Surg Oncol. 2004;10:1039–47.CrossRef Cox CE, Furman B, Stowell N, et al. Radioactive seed localization breast biopsy and lumpectomy: can specimen radiograph be eliminated? Ann Surg Oncol. 2004;10:1039–47.CrossRef
16.
Zurück zum Zitat Sung JS, King V, Thornton CM, et al. Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy. Eur J Radiol. 2013;82:1453–7.PubMedCrossRef Sung JS, King V, Thornton CM, et al. Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy. Eur J Radiol. 2013;82:1453–7.PubMedCrossRef
17.
Zurück zum Zitat Thind CR, Tan S, Desmond S, et al. SNOLL: sentinel node and occult (impalpable) lesion localization in breast cancer. Clin Radiol. 2011;66:833–9.PubMedCrossRef Thind CR, Tan S, Desmond S, et al. SNOLL: sentinel node and occult (impalpable) lesion localization in breast cancer. Clin Radiol. 2011;66:833–9.PubMedCrossRef
18.
Zurück zum Zitat Lovrics PJ, Goldsmith CH, Hodgson N, et al. A multicenter randomized controlled trial comparing radio-guided seed localization to standard wire localization for nonpalpable, invasive, and in situ breast carcinoma. Ann Surg Oncol. 2011;18:3407–14.PubMedCrossRef Lovrics PJ, Goldsmith CH, Hodgson N, et al. A multicenter randomized controlled trial comparing radio-guided seed localization to standard wire localization for nonpalpable, invasive, and in situ breast carcinoma. Ann Surg Oncol. 2011;18:3407–14.PubMedCrossRef
19.
Zurück zum Zitat Thompson M, Klimberg VS. Use of breast ultrasound in surgery. Surg Clin North Am. 2007;87:469–84.PubMedCrossRef Thompson M, Klimberg VS. Use of breast ultrasound in surgery. Surg Clin North Am. 2007;87:469–84.PubMedCrossRef
20.
Zurück zum Zitat Smith LF, Rubio IT, Henry-Tillman R, et al. Intraoperative ultrasound-guided breast biopsy. Am J Surg. 2000;180:419–23.PubMedCrossRef Smith LF, Rubio IT, Henry-Tillman R, et al. Intraoperative ultrasound-guided breast biopsy. Am J Surg. 2000;180:419–23.PubMedCrossRef
21.
Zurück zum Zitat Rahusen FD, Bremers AJA, Fabry HFJ, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol. 2002;9:994–8.PubMedCrossRef Rahusen FD, Bremers AJA, Fabry HFJ, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol. 2002;9:994–8.PubMedCrossRef
22.
Zurück zum Zitat Moore MM, Whitney LA, Cerilli L, Imbrie JZ, Bunch M, Simpson VB, Hanks JB. Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer. Ann Surg. 2001;233:761–8.PubMedPubMedCentralCrossRef Moore MM, Whitney LA, Cerilli L, Imbrie JZ, Bunch M, Simpson VB, Hanks JB. Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer. Ann Surg. 2001;233:761–8.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Ahmed M, Douek M. Intraoperative ultrasound versus wire-localization in the surgical management of non palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res Treat. 2013;140:435–46.PubMedCrossRef Ahmed M, Douek M. Intraoperative ultrasound versus wire-localization in the surgical management of non palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res Treat. 2013;140:435–46.PubMedCrossRef
24.
Zurück zum Zitat Blumencranz PW, Ellis D, Barlowe K. Use of hydrogel breast biopsy tissue markers reduces the need for wire localization. Ann Surg Oncol. 2014;21:3272–7.CrossRef Blumencranz PW, Ellis D, Barlowe K. Use of hydrogel breast biopsy tissue markers reduces the need for wire localization. Ann Surg Oncol. 2014;21:3272–7.CrossRef
25.
Zurück zum Zitat Van Riet YE, Maaskant AJ, Creemers GJ, et al. Identification of residual breast tumor localization after neoadjuvant chemotherapy using a radioactive 125 iodine seed. Eur J Surg Oncol. 2010;36:164–9.PubMedCrossRef Van Riet YE, Maaskant AJ, Creemers GJ, et al. Identification of residual breast tumor localization after neoadjuvant chemotherapy using a radioactive 125 iodine seed. Eur J Surg Oncol. 2010;36:164–9.PubMedCrossRef
26.
Zurück zum Zitat Gobardhan PD, de Wall LL, van der Laan L, et al. The role of radioactive iodine-125 seed localization in breast-conserving therapy following neoadjuvant chemotherapy. Ann Oncol. 2012;24:668–73.PubMedCrossRef Gobardhan PD, de Wall LL, van der Laan L, et al. The role of radioactive iodine-125 seed localization in breast-conserving therapy following neoadjuvant chemotherapy. Ann Oncol. 2012;24:668–73.PubMedCrossRef
27.
Zurück zum Zitat Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guidelines (version 1.1). Eur J Cancer. 2009;45:228–47.PubMedCrossRef Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guidelines (version 1.1). Eur J Cancer. 2009;45:228–47.PubMedCrossRef
28.
Zurück zum Zitat Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, Schofield A, Heys SD. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast. 2003;12:320–7.PubMedCrossRef Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, Schofield A, Heys SD. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast. 2003;12:320–7.PubMedCrossRef
29.
Zurück zum Zitat Boughey JC, Peintinger F, Meric-Bernstam F, et al. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg. 2006;244:464–70.PubMedPubMedCentral Boughey JC, Peintinger F, Meric-Bernstam F, et al. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg. 2006;244:464–70.PubMedPubMedCentral
30.
Zurück zum Zitat Criscitiello C, Azim HA Jr, Agbor-Tarh D, et al. Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial. Ann Oncol. 2013;24:1980–5.PubMedCrossRef Criscitiello C, Azim HA Jr, Agbor-Tarh D, et al. Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial. Ann Oncol. 2013;24:1980–5.PubMedCrossRef
31.
Zurück zum Zitat Debled M, MacGrogan G, Breton-Callu C, et al. Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer: time to reconsider the standard attitude. Eur J Cancer. 2015;51:697–704.PubMedCrossRef Debled M, MacGrogan G, Breton-Callu C, et al. Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer: time to reconsider the standard attitude. Eur J Cancer. 2015;51:697–704.PubMedCrossRef
32.
Zurück zum Zitat Kass R, Kumar G, Klimber VS, et al. Clip migration in stereotactic biopsy. Am J Surg. 2002;184:325–31.PubMedCrossRef Kass R, Kumar G, Klimber VS, et al. Clip migration in stereotactic biopsy. Am J Surg. 2002;184:325–31.PubMedCrossRef
33.
Zurück zum Zitat Krekel NM, Lopes Cardozo AM, Muller S, et al. Optimizing surgical accuracy in palpable breast cancer with intra operative breast ultrasound-feasibility and surgeon’s learning curve. Eur J Surg Oncol. 2011;37:1044–50.PubMedCrossRef Krekel NM, Lopes Cardozo AM, Muller S, et al. Optimizing surgical accuracy in palpable breast cancer with intra operative breast ultrasound-feasibility and surgeon’s learning curve. Eur J Surg Oncol. 2011;37:1044–50.PubMedCrossRef
34.
Zurück zum Zitat Wazer DE, DiPetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 1992;10:356–63.PubMed Wazer DE, DiPetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 1992;10:356–63.PubMed
35.
Zurück zum Zitat Krekel N, Zonderhuis B, Schreurs H, et al. Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life: a prospective multicentre randomized controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial). BMC Surg. 2011;11:8.PubMedPubMedCentralCrossRef Krekel N, Zonderhuis B, Schreurs H, et al. Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life: a prospective multicentre randomized controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial). BMC Surg. 2011;11:8.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Cochrane RA, Valasiadou P, Wilson AR, et al. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg. 2003;90:1505–9.PubMedCrossRef Cochrane RA, Valasiadou P, Wilson AR, et al. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg. 2003;90:1505–9.PubMedCrossRef
37.
Zurück zum Zitat Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014;21:704–16.PubMedCrossRef Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014;21:704–16.PubMedCrossRef
38.
Zurück zum Zitat Truin W, Vugts G, Roumen RM, et al. Differences in response and surgical management with neoadjuvant chemotherapy in invasive lobular versus ductal breast cancer. Ann Surg Oncol. 2015. Epub ahead of print. Truin W, Vugts G, Roumen RM, et al. Differences in response and surgical management with neoadjuvant chemotherapy in invasive lobular versus ductal breast cancer. Ann Surg Oncol. 2015. Epub ahead of print.
Metadaten
Titel
Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment
verfasst von
Isabel T. Rubio, MD, PhD
Antonio Esgueva-Colmenarejo, MD
Martin Espinosa-Bravo, MD, PhD
Juan Pablo Salazar, MD
Ignacio Miranda, MD
Vicente Peg, MD, PhD
Publikationsdatum
01.01.2016
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4935-z

Weitere Artikel der Ausgabe 1/2016

Annals of Surgical Oncology 1/2016 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.